Normal urinary growth hormone measurement in short-stature early pubertal boys may help to exclude growth hormone deficiency
Related Experiment Video
Updated: Aug 15, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
1Division of Endocrinology, Faculty of Medicine, Ribeirão Preto, São Paulo, Brazil.
Insights
Urinary growth hormone (U-GH) measurement can predict growth rates in short-stature boys. Higher U-GH levels in these boys may indicate normal growth, potentially delaying provocative testing.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Physiology
Background:
- Constitutional short stature (CSS) in boys presents diagnostic challenges.
- Assessing growth hormone (GH) secretion is crucial for managing short stature.
- Pharmacological tests for GH deficiency can be invasive and sometimes yield ambiguous results.
Purpose of the Study:
- To evaluate the utility of urinary growth hormone (U-GH) as a predictor of growth rate in young boys.
- To compare U-GH levels in boys with CSS to those in normal and GH-deficient children.
Main Methods:
- U-GH concentrations were measured in five early pubertal boys with CSS.
- U-GH levels were compared with those from normal prepubertal/pubertal children and GH-deficient children.
- U-GH results were correlated with subsequent growth rates and plasma GH responses to provocative tests.
Main Results:
- In boys with CSS, U-GH levels ranged from 3.7 to 9.7 ng/night, indicating normal growth potential despite blunted plasma GH responses.
- Normal prepubertal and pubertal children had U-GH levels of 2.2 +/- 0.2 and 4.1 +/- 0.5 ng/night, respectively.
- GH-deficient children showed lower U-GH levels (1.1 +/- 0.2 ng/night) compared to CSS and normal groups.
Conclusions:
- U-GH measurement appears to be a useful indicator of subsequent growth rate in early pubertal boys with CSS.
- U-GH may normalize earlier than provocative GH testing, especially with rising sex steroids.
- U-GH values above 2.6 ng/night in CSS boys might warrant delaying provocative tests and observing growth.
Objective:
To determine whether urinary growth hormone (U-GH) measurement is a useful indicator of subsequent growth rate in young boys.
Methods:
We assessed the U-GH concentrations in five early pubertal boys with constitutional short stature (CSS) who were referred to a growth clinic and compared the results with those obtained in normal children and in children with GH deficiency.
Results:
In the five early pubertal short-stature boys, the U-GH concentration ranged from 3.7 to 9.7 ng/night and, despite their blunted plasma GH responses to two different pharmacologic tests (peak plasma GH <7 ng/mL), proved to be a useful indicator of their subsequent normal growth rate. The U-GH was 2.2 +/- 0.2 and 4.1 +/- 0.5 ng/night in 38 normal prepubertal and pubertal children, respectively, 2.4 +/- 0.2 ng/night in 13 subjects with CSS, and 1.1 +/- 0.2 ng/night in 16 GH-deficient short-stature children.
Conclusion:
We may speculate that 24-hour GH secretion and possibly U-GH normalize sooner than do responses to provocative testing as sex steroids appear in early pubertal constitutional short-stature boys. From a practical standpoint, it seems that U-GH values higher than 2.6 ng/night (mean + SE value for subjects with CSS) in such patients may justify postponement of the pharmacologic tests and waiting for growth during the subsequent year.
Related Concept Videos
Nature and Nurture
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Serum Studies: Renal Function Tests

